临床试验公共管理平台 Clinical Trial Management Public Platform

当前位置：Public Access >页面

Chinese/English

Anlotinib plus albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or peritoneal carcinoma (A-Plus): a phase II, single-arm, prospective study

Filter Options
Patient No.		Patient Name		Patient Gender
Sitting		Education		Date of enrollment	FromTo
	More Options

Patient No	Gender	Date of enrollment	Sitting	Creater	Operate
NO participants recorded。

0/0

提示：推荐使用chrome浏览器并且在宽屏显示分辨率下使用系统。

Copyright(c) (2010-2013) .All rights reserved.临床试验公共管理平台版权所有